177 related articles for article (PubMed ID: 25270513)
1. Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways.
Gao L; Phan S; Nadora DM; Chernova M; Sun V; Preciado SM; Ballew B; Jia Z; Jia W; Wang G; Mihm MC; Nelson JS; Tan W
Lasers Surg Med; 2014 Nov; 46(9):679-88. PubMed ID: 25270513
[TBL] [Abstract][Full Text] [Related]
2. Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels.
Tan W; Jia W; Sun V; Mihm MC; Nelson JS
Lasers Surg Med; 2012 Dec; 44(10):796-804. PubMed ID: 23213008
[TBL] [Abstract][Full Text] [Related]
3. Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser.
Gao L; Nadora DM; Phan S; Chernova M; Sun V; Preciado SM; Jia W; Wang G; Mihm MC; Nelson JS; Tan W
Br J Dermatol; 2015 Mar; 172(3):669-76. PubMed ID: 25283693
[TBL] [Abstract][Full Text] [Related]
4. Topical metformin suppresses angiogenesis pathways induced by pulsed dye laser irradiation in animal models.
Wang M; Lin Y; Shi W; Chen X; Mi Z; Jia Z; Pan Q; Wang Z; Han J; Liu H
Exp Dermatol; 2022 Mar; 31(3):393-397. PubMed ID: 34564891
[TBL] [Abstract][Full Text] [Related]
5. Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks.
Loewe R; Oble DA; Valero T; Zukerberg L; Mihm MC; Nelson JS
J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):76-82. PubMed ID: 20482679
[TBL] [Abstract][Full Text] [Related]
6. Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment.
Griffin TD; Foshee JP; Finney R; Saedi N
Lasers Surg Med; 2016 Feb; 48(2):193-6. PubMed ID: 26503090
[TBL] [Abstract][Full Text] [Related]
7. Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation.
Doh EJ; Ohn J; Kim MJ; Kim YG; Cho S
J Dermatolog Treat; 2017 Nov; 28(7):672-677. PubMed ID: 28285560
[TBL] [Abstract][Full Text] [Related]
8. Topical Adjuncts to Pulsed Dye Laser for Treatment of Port Wine Stains: Review of the Literature.
Lipner SR
Dermatol Surg; 2018 Jun; 44(6):796-802. PubMed ID: 29799824
[TBL] [Abstract][Full Text] [Related]
9. Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application.
Artzi O; Mehrabi JN; Heyman L; Friedman O; Mashiah J
Dermatol Ther; 2020 Jan; 33(1):e13172. PubMed ID: 31747115
[TBL] [Abstract][Full Text] [Related]
10. Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.
Greveling K; Prens EP; van Doorn MB
Lasers Surg Med; 2017 Jan; 49(1):104-109. PubMed ID: 27320685
[TBL] [Abstract][Full Text] [Related]
11. Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment.
Jia W; Sun V; Tran N; Choi B; Liu SW; Mihm MC; Phung TL; Nelson JS
Lasers Surg Med; 2010 Feb; 42(2):105-12. PubMed ID: 20166161
[TBL] [Abstract][Full Text] [Related]
12. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial.
Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
J Am Acad Dermatol; 2015 Jan; 72(1):151-8.e1. PubMed ID: 25455610
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial.
Fallahi M; Hallaji Z; Tavakolpour S; Niknam S; Salehi Farid A; Nili A; Teimourpour A; Daneshpazhooh M; Rahmati J; Haddady Abianeh S; Mahmoudi H
J Cosmet Dermatol; 2021 Aug; 20(8):2498-2506. PubMed ID: 33251650
[TBL] [Abstract][Full Text] [Related]
14. Initial research on the effect and mechanism of Tivozanib on pulsed dye laser induced angiogenesis.
Wang B; Zhang Y; Lou Y; Hu X; Li F
Lasers Surg Med; 2022 Oct; 54(8):1157-1166. PubMed ID: 35916102
[TBL] [Abstract][Full Text] [Related]
15. Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results.
Bloom BS; Nelson JS; Geronemus RG
J Am Acad Dermatol; 2015 Aug; 73(2):e71. PubMed ID: 26184004
[No Abstract] [Full Text] [Related]
16. Delayed ulceration following combination pulse dye laser and topical sirolimus treatment for port wine birthmarks: A case series.
Hobayan CGP; Nourse EJ; Paradiso MM; Fernandez Faith E
Pediatr Dermatol; 2024; 41(1):108-111. PubMed ID: 37571864
[TBL] [Abstract][Full Text] [Related]
17. Reply to: "Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results".
Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
J Am Acad Dermatol; 2015 Aug; 73(2):e73-4. PubMed ID: 26184005
[No Abstract] [Full Text] [Related]
18. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone.
Musalem HM; Alshaikh AA; Tuleimat LM; Alajlan S
Ann Saudi Med; 2018; 38(5):376-380. PubMed ID: 30284993
[TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of port wine stains before and after pulsed dye laser treatment.
Laquer VT; Hevezi PA; Albrecht H; Chen TS; Zlotnik A; Kelly KM
Lasers Surg Med; 2013 Feb; 45(2):67-75. PubMed ID: 23440713
[TBL] [Abstract][Full Text] [Related]
20. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks.
Chang CJ; Hsiao YC; Mihm MC; Nelson JS
Lasers Surg Med; 2008 Nov; 40(9):605-10. PubMed ID: 18951427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
